PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $310,000 | -8.8% | 5,829 | 0.0% | 0.03% | -3.7% |
| Q2 2022 | $340,000 | -0.9% | 5,829 | +29.8% | 0.03% | +22.7% |
| Q1 2022 | $343,000 | +29.9% | 4,490 | +2.4% | 0.02% | +57.1% |
| Q4 2021 | $264,000 | +20.5% | 4,383 | +12.3% | 0.01% | +7.7% |
| Q3 2021 | $219,000 | +2.8% | 3,904 | +11.1% | 0.01% | 0.0% |
| Q2 2021 | $213,000 | -25.3% | 3,513 | -13.7% | 0.01% | -31.6% |
| Q1 2021 | $285,000 | – | 4,070 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |